Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer
Authors
Keywords
-
Journal
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
Volume 71, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-08-11
DOI
10.1007/s00005-023-00684-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
- (2023) Giuseppe Schepisi et al. Cancers
- Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
- (2022) Mohsen Sheykhhasan et al. CANCER GENE THERAPY
- Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer
- (2022) Raquel Cruz-Duarte et al. CLINICAL CANCER RESEARCH
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
- (2022) Hendrik Setia Budi et al. Stem Cell Research & Therapy
- CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
- (2022) Chiara Corti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mesothelin: An Immunotherapeutic Target beyond Solid Tumors
- (2022) Joshua R. Faust et al. Cancers
- Construction of a 124I-Labeled Specific Antibody for the Noninvasive Detection of Mesothelin-Overexpressing Tumors
- (2022) Xingguo Hou et al. MOLECULAR PHARMACEUTICS
- Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signaling
- (2022) Min Zhou et al. MOLECULAR THERAPY
- The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab‐containing regimens
- (2022) Elif Sertesen et al. ANZ JOURNAL OF SURGERY
- Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial
- (2022) Xiao-Feng Xie et al. BREAST CANCER RESEARCH AND TREATMENT
- Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a systematic review and meta-analysis
- (2022) Kathryn Owen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Beyond HER2: Targeting the ErbB receptor family in breast cancer
- (2022) Joshua Z. Drago et al. CANCER TREATMENT REVIEWS
- Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
- (2022) Chunrun Qu et al. Molecular Cancer
- The journey of CAR-T therapy in hematological malignancies
- (2022) Junru Lu et al. Molecular Cancer
- Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
- (2022) Nieves Martínez-Lago et al. Scientific Reports
- Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
- (2022) Ali Keshavarz et al. Stem Cell Research & Therapy
- Recent advances in CAR-T cells therapy for colorectal cancer
- (2022) Xiaoling Qin et al. Frontiers in Immunology
- The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
- (2022) Zhang Guizhen et al. Frontiers in Endocrinology
- CAR T-cells for colorectal cancer immunotherapy: Ready to go?
- (2022) Bouchra Ghazi et al. Frontiers in Immunology
- Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
- (2021) Babak Moghimi et al. Nature Communications
- Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
- (2021) Jiaqiao Fan et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA approves first BCMA-targeted CAR-T cell therapy
- (2021) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
- (2021) Axel Hyrenius-Wittsten et al. Science Translational Medicine
- Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
- (2021) Lin Xia et al. Cancer Immunology Research
- Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C
- (2021) Vishwas Mishra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel antigens of CAR T cell therapy: New roads; old destination
- (2021) Pooria Safarzadeh Kozani et al. Translational Oncology
- Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody–drug conjugates from synthetic antibody libraries
- (2021) Hung-Ju Hsu et al. Scientific Reports
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses
- (2021) Yanping Yang et al. Cancer Immunology Research
- Control of the activity of CAR-T cells within tumours via focused ultrasound
- (2021) Yiqian Wu et al. Nature Biomedical Engineering
- Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
- (2021) Taylor C. Brown et al. Biomolecules
- Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo
- (2021) Guodi Liu et al. EXPERIMENTAL CELL RESEARCH
- Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
- (2021) Saisha A Nalawade et al. Journal for ImmunoTherapy of Cancer
- Oncolytic adenovirus targeting TGF-β enhances anti-tumor responses of mesothelin-targeted chimeric antigen receptor T cell therapy against breast cancer
- (2020) Yuxiang Li et al. CELLULAR IMMUNOLOGY
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma
- (2020) Joseph C Ahn et al. HEPATOLOGY
- A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
- (2020) Gábor Tóth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
- (2020) Parvez Vora et al. Cell Stem Cell
- Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
- (2020) Elham Masoumi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer
- (2020) Megan Minnix et al. Cancer Medicine
- The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
- (2020) Marco Cerrano et al. Frontiers in Immunology
- Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies
- (2020) Árpád Szöőr et al. CANCER LETTERS
- Experimental treatment of colorectal cancer in mice with human T cells electroporated with NKG2D RNA CAR
- (2020) Zhendong Li et al. Immunotherapy
- Recent advances in CAR-T cell engineering
- (2020) Ruihao Huang et al. Journal of Hematology & Oncology
- Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
- (2020) Emmanuel Donnadieu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.
- (2020) M.-L. Schubert et al. ANNALS OF ONCOLOGY
- CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
- (2020) Jessica Wagner et al. MOLECULAR THERAPY
- Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7
- (2020) Christina Amatya et al. MOLECULAR THERAPY
- Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis
- (2020) Yin He et al. Annals of Translational Medicine
- PD-1 silencing improves anti-tumor activities of human mesothelin-targeted CAR T cells
- (2020) Guodi Liu et al. HUMAN IMMUNOLOGY
- The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth
- (2020) Pengxiang Yang et al. CELLULAR IMMUNOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CRISPR–Cas: a tool for cancer research and therapeutics
- (2019) Hao Yin et al. Nature Reviews Clinical Oncology
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Mechanisms of resistance to CAR T cell therapy
- (2019) Nirali N. Shah et al. Nature Reviews Clinical Oncology
- Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
- (2019) Katrine Wickstroem et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of Chimeric Antigen Receptor–Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer
- (2019) Bing-Lan Zhang et al. HUMAN GENE THERAPY
- Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
- (2019) Shivani Srivastava et al. CANCER CELL
- CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs
- (2019) F. Rahbarizadeh et al. ADVANCED DRUG DELIVERY REVIEWS
- Mesothelin-targeted thorium-227 conjugate (MSLN-TTC): Preclinical evaluation of a new targeted alpha therapy for mesothelin-positive cancers
- (2019) Urs B Hagemann et al. CLINICAL CANCER RESEARCH
- HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
- (2019) Steven C. Katz et al. CANCER GENE THERAPY
- Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
- (2019) Chelsea Kotch et al. Expert Review of Clinical Immunology
- Managing the toxicities of CAR T‐cell therapy
- (2019) Sattva S. Neelapu HEMATOLOGICAL ONCOLOGY
- Cellular therapy: Immune‐related complications
- (2019) Joseph H. Oved et al. IMMUNOLOGICAL REVIEWS
- Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors
- (2019) Andreas A. Hombach et al. MOLECULAR THERAPY
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes
- (2019) Hany E. Marei et al. BIOCHEMICAL PHARMACOLOGY
- Gasdermins and their role in immunity and inflammation
- (2019) Pontus Orning et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The potential and controversy of targeting STAT family members in cancer
- (2019) Yannick Verhoeven et al. SEMINARS IN CANCER BIOLOGY
- PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
- (2019) Eileen McGowan et al. BIOMEDICINE & PHARMACOTHERAPY
- IL‐18R‐dependent and independent pathways account for IL‐18‐enhanced antitumor ability of CAR‐T cells
- (2019) Yong Huang et al. FASEB JOURNAL
- Clinical indications for, and the future of, circulating tumor cells
- (2018) Dominic H. Moon et al. ADVANCED DRUG DELIVERY REVIEWS
- Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer
- (2018) Maren Knödler et al. BRITISH JOURNAL OF CANCER
- The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline
- (2018) Elisabeth F. P. Peterse et al. CANCER
- Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression
- (2018) Balsam Rizeq et al. CANCER SCIENCE
- Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells
- (2018) Bian Hu et al. HUMAN GENE THERAPY
- Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
- (2018) Dok Yoon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering chimeric antigen receptor-T cells for cancer treatment
- (2018) Baixin Ye et al. Molecular Cancer
- Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
- (2018) Christopher W. Mount et al. NATURE MEDICINE
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
- (2018) Michael S. Magee et al. Cancer Immunology Research
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
- (2018) Jie Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy
- (2018) Erhao Zhang et al. Journal of Hematology & Oncology
- CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease
- (2018) Katherine C. Pehlivan et al. Current Hematologic Malignancy Reports
- GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
- (2018) Rosalie M. Sterner et al. BLOOD
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
- (2018) Ruidi Teng et al. JOURNAL OF IMMUNOTHERAPY
- The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma
- (2018) Junhun Cho et al. PATHOLOGY RESEARCH AND PRACTICE
- Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy
- (2018) Irene S. Yu et al. Canadian Journal of Gastroenterology and Hepatology
- Making CAR T Cells a Solid Option for Solid Tumors
- (2018) Andrea Schmidts et al. Frontiers in Immunology
- New development in CAR-T cell therapy
- (2017) Zhenguang Wang et al. Journal of Hematology & Oncology
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Immunotherapy: Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers
- (2017) Vinay Prasad Nature Reviews Clinical Oncology
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
- (2017) Oladapo O. Yeku et al. Scientific Reports
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy
- (2017) Carole Fournier et al. OncoImmunology
- CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy
- (2017) Nan Chen et al. OncoImmunology
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA)
- (2016) J.C. Sachdev et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells
- (2016) Michael Boice et al. CELL
- Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer
- (2016) Andreas Seeber et al. INTERNATIONAL JOURNAL OF CANCER
- Guanylyl cyclase C signaling axis and colon cancer prevention
- (2016) Amanda M Pattison et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
- (2016) Gustaw Lech WORLD JOURNAL OF GASTROENTEROLOGY
- ICOS Co-Stimulation: Friend or Foe?
- (2016) Daniel J. Wikenheiser et al. Frontiers in Immunology
- GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
- (2016) Michael S. Magee et al. OncoImmunology
- Chimeric antigen receptor T-cell therapy for solid tumors
- (2016) Kheng Newick et al. Molecular Therapy-Oncolytics
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- TRUCKs: the fourth generation of CARs
- (2015) Markus Chmielewski et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer
- (2015) Mei-Ying Liao et al. Oncotarget
- Real-Time Visualizing and Tracing of HSV-TK/GCV Suicide Gene Therapy by Near-Infrared Fluorescent Quantum Dots
- (2014) Dan Shao et al. ACS Applied Materials & Interfaces
- Cancer CARtography: charting out a new approach to cancer immunotherapy
- (2014) Jaina M Patel et al. Immunotherapy
- Interdependent epidermal growth factor receptor signalling and trafficking
- (2014) Sylwia Jones et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
- (2014) Anat Globerson-Levin et al. MOLECULAR THERAPY
- Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
- (2014) Ge Zhang et al. Scientific Reports
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
- (2013) V S Warneke et al. BRITISH JOURNAL OF CANCER
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer
- (2013) Dominic Fong et al. HISTOPATHOLOGY
- Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
- (2013) Angharad Lloyd et al. Frontiers in Immunology
- Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies
- (2012) Ulrike Weissenstein et al. BMC CANCER
- Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
- (2012) Grazyna Lipowska-Bhalla et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Associated Glycoprotein-72 is a Novel Marker for Poor Survival in Hepatocellular Carcinoma
- (2012) Yang Zhang et al. PATHOLOGY & ONCOLOGY RESEARCH
- Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
- (2011) H. Singh et al. CANCER RESEARCH
- Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
- (2011) Carlo Patriarca et al. CANCER TREATMENT REVIEWS
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Immunoreactivity and prognostic value of tumor-associated glycoprotein 72 in primary gallbladder carcinoma
- (2009) Miao Ouyang et al. SURGICAL ONCOLOGY-OXFORD
- Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
- (2008) N. Nishimoto et al. BLOOD
- MUC1 and colorectal cancer pathophysiology considerations
- (2008) Yaron Niv WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now